NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
84 hedge funds and large institutions have $667M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
84
Holding in Top 10
4
Calls
$13K
Puts
–
Top Buyers
| 1 | +$18.5M | |
| 2 | +$10.4M | |
| 3 | +$7.58M | |
| 4 |
Morgan Stanley
New York
|
+$3.61M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.6M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$3.49M | |
| 3 | -$2.82M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.48M |
| 5 |
Millennium Management
New York
|
-$1.65M |